Tessie McNeely
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Antimicrobial Resistance in Staphylococcus, Bacterial biofilms and quorum sensing, Research on Leishmaniasis Studies, Trypanosoma species research and implications, HIV Research and Treatment
Most-Cited Works
- → Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro.(1995)431 cited
- → Effect of an Investigational Vaccine for Preventing Staphylococcus aureus Infections After Cardiothoracic Surgery(2013)361 cited
- → A Novel Staphylococcus aureus Vaccine: Iron Surface Determinant B Induces Rapid Antibody Responses in Rhesus Macaques and Specific Increased Survival in a Murine S. aureus Sepsis Model(2006)258 cited
- → Inhibition of Human Immunodeficiency Virus Type 1 Infectivity by Secretory Leukocyte Protease Inhibitor Occurs Prior to Viral Reverse Transcription(1997)245 cited
- → Secretory leukocyte protease inhibitor suppresses the production of monocyte prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinases.(1997)183 cited
- → Requirement of lipophosphoglycan for intracellular survival of Leishmania donovani within human monocytes.(1990)141 cited